HGVLY News Alert Evraz Highveld ADR (HGVLY) 0.2600 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Evraz Highveld ADR (HGVLY) 0.2600 $HGVLY

Global and Chinese Vanadium Industry Report, 2014-2017
M2 - Thu Dec 04, 5:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/whnrrj/global_and) has announced the addition of the "Global and Chinese Vanadium Industry Report, 2014-2017" report to their offering. China, the world's largest vanadium-producing country with a capacity of over 100 kt/a, contributed 57% to the world's vanadium (V2O5 Equivalent) production in 2013. It also has the fastest-growing and highest consumption of vanadium products in the world, with vanadium (V2O5 Equivalent) consumption rising from 5.3 kilotons to 57 kilotons in 2001-2013 (an AAGR of 22% or so) as a result of promotion and use of vanadium-containing high-strength deformed steel bars grade III and grade IV. China's vanadium industry is highly concentrated in Pangang Group Vanadium Titanium & Resources Co., Ltd., Hebei Iron & Steel Group Co., Ltd. and other big steelmakers since most of the early vanadium ore investors such as Xining Special Steel Co., Ltd., Zhejiang Hailiang Co., Ltd. and Shanghai Dingli Technology Development (Group) Co., Ltd. haven't entered substantial production yet. Pangang Group Vanadium Titanium & Resources as China's largest vanadium production enterprise now boasts a production capacity of 20 kt/a vanadium product (V2O5 Equivalent). Besides, it is the only high-vanadium ferroalloy (FeV80) manufacturer there. In the first half of 2014, the company's vanadium products reaped RMB1.61 billion in revenue, down 4.8% year on year. Hebei Iron & Steel is one of the largest vanadium-titanium production bases in China. It now has six vanadium-nitrogen alloy production lines, with products exported to more than 10 countries and regions, representing an approximately 8% share in global vanadium market. The company's revenue from vanadium products in the first half of 2014 was RMB388 million, up 2.4% year on year. Key Topics Covered: 1. Introduction to Vanadium 2. Global Vanadium Market 3. China Vanadium Market 4. Major Vanadium Manufacturers in the World 5. Major Vanadium Manufacturers in China 6. Summary and Forecast Companies Mentioned - American Vanadium Corp - Atlantic Ltd - Chengdu Tianxing Instrument And Meter - Evraz - Guangdong Boxin Investing & Holdings - Hebei Iron & Steel - Highveld Steel and Vanadium Corporation - Pangang Group Vanadium Titanium & Resources - Shanghai Dingli Technology Development - Sichuan Mingxing Electric Power - Xining Special Steel - Zhejiang Hailiang For more information visit http://www.researchandmarkets.com/research/whnrrj/global_and

POSCO (PKX) Q3 Earnings Fall Y/Y, 2014 Outlook Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 1:50PM CDT
POSCO (PKX) reported a disappointing third-quarter 2014 results, with net earnings plummeting 60.3% year over year to KRW 224 billion (US$0.22 billion). Earnings came in at KRW 2,567.3 per share or US$0.63 per American Depository Receipt.
FSTR: 49.28 (+0.41), MTL: 0.71 (-0.06), PKX: 64.48 (+0.02)

AK Steel Holding Corporation (AKS) Jumps: Stock Rises 9.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 8:11AM CDT
AK Steel Holding Corporation (AKS) was a big mover last session, as the company saw its shares rise over 9% on the day.
FSTR: 49.28 (+0.41), AKS: 5.76 (+0.11)

Strength Seen in Mechel OAO (MTL): Stock Soars 12.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 8:21AM CDT
Mechel OAO (MTL) was a big mover last session, as the company saw its shares rise by over 12% on the day.
MTL: 0.71 (-0.06), X: 26.51 (+0.11)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading